Sutro Biopharma is a clinical-stage biotechnology company focused on discovering, developing, and manufacturing precisely designed cancer therapeutics. They leverage a proprietary cell-free protein synthesis platform, XpressCF®, to create novel antibody-drug conjugates (ADCs) and other protein-based therapeutics.